Germany-based medical technology company Microstim secured series A funding worth €1.5m ($2m) on Thursday from a pool of Germany-based investors including federal state fund Technologiefonds MV, the corporate-backed venture capital fund High-Tech Gründerfonds and Fides Finanz-Invest, a division of the Jasika property group. High-Tech Gründerfonds previously supplied seed financing to Microstim in February 2009, investing €500,000. Founded in 2007, Microstim constructs implantable ventricular devices that assist the preservation of the heart’s muscle and tissue function. Microstim plans to use the funding to develop and market its muscle stimulator device.
- News & Analysis
- Global Corporate Venturing
- Global University Venturing
- Latest News
- Deal Data
- Community & Events
Microstim takes heart with German backers
Oct 10, 2011 • Robert Lavine
LEADERSHIP SOCIETYInforming, connecting, and transforming the global corporate venture capital ecosystem.
The Global Corporate Venturing (GCV) Leadership Society’s mission is to help bridge the different strengths and ambitions of investors across industry sectors, geography, structure, and their returns.
Featured ContentFUNDING ROUND DATA Which corporates are backing which startups? Search our corporate deal database.
FUNDING ROUND DATA
Which corporates are backing which startups? Search our corporate deal database.NOMINATE Nominations for the GCV Powerlist 2024 are now open
Nominations for the GCV Powerlist 2024 are now openEventsWebinar: Startups and Strategics – What works and what doesn’tEventsGCV Institute: Landing the Value of Corporate VenturingTop News
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.test reg